Paper · 38415019
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.
Kjærgaard K and 11 others. JHEP Rep, 2024. Cited by 36 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation. Papers, record 38415019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38415019
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21,119,734 | Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. | Nat Rev Drug Discov | 2010 | https://conductscience.org/library/papers/21119734 | PubMed |
| 2 | 23,046,210 | Review: systemic inflammation and Alzheimer's disease. | Neuropathol Appl Neurobiol | 2013 | https://conductscience.org/library/papers/23046210 | PubMed |
| 3 | 34,440,206 | Rifaximin Prevents T-Lymphocytes and Macrophages Infiltration in Cerebellum and Restores Motor Incoordination in Rats with Mild Liver Damage. | Biomedicines | 2021 | https://conductscience.org/library/papers/34440206 | PubMed |
| 4 | 28,314,735 | Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. | Gut | 2017 | https://conductscience.org/library/papers/28314735 | PubMed |
| 5 | 35,681,418 | Different Methods for Evaluating Microglial Activation Using Anti-Ionized Calcium-Binding Adaptor Protein-1 Immunohistochemistry in the Cuprizone Model. | Cells | 2022 | https://conductscience.org/library/papers/35681418 | PubMed |
| 6 | 37,425,212 | Role of ammonia in NAFLD: An unusual suspect. | JHEP Rep | 2023 | https://conductscience.org/library/papers/37425212 | PubMed |
| 7 | 33,961,787 | Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. | Lancet Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33961787 | PubMed |
| 8 | 34,642,213 | Hippocampus-Prefrontal Coupling Regulates Recognition Memory for Novelty Discrimination. | J Neurosci | 2021 | https://conductscience.org/library/papers/34642213 | PubMed |
| 9 | 16,618,517 | Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. | J Hepatol | 2006 | https://conductscience.org/library/papers/16618517 | PubMed |
| 10 | 33,572,481 | Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives. | J Clin Med | 2021 | https://conductscience.org/library/papers/33572481 | PubMed |
1 to 10 of 50
See all 50 referencesCited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,689,015 | Liver-nervous system axis in MASLD: mechanistic insights and emerging targeted therapies. | eGastroenterology | 2026 | https://conductscience.org/library/papers/42689015 | PubMed |
| 42,566,291 | Suicide mortality in metabolic dysfunction-associated liver diseases: a nationwide cohort study. | Ann Med | 2026 | https://conductscience.org/library/papers/42566291 | PubMed |
| 42,483,871 | Closer Association of Liver Stiffness Than Liver Fat Content With Imaging-Derived Neurovascular Coupling in a Metabolic Dysfunction-Associated Steatotic Liver Disease Cohort. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42483871 | PubMed |
| 42,465,741 | Exercise-conditioned extracellular vesicles in Alzheimer's disease: a multi-organ signaling network linking peripheral adaptation to brain pathology. | Front Immunol | 2026 | https://conductscience.org/library/papers/42465741 | PubMed |
| 42,451,045 | Ultra-Processed Foods, MASLD, and Cognitive Aging: A Processing-Centered Gut-Liver-Brain Axis Perspective. | Nutrients | 2026 | https://conductscience.org/library/papers/42451045 | PubMed |
| 42,409,068 | MASH-Associated T Cell Activation and Neuroinflammation: Evidence for a Hepatosystemic Immune Axis. | Semin Liver Dis | 2026 | https://conductscience.org/library/papers/42409068 | PubMed |
| 42,249,678 | Abdominal adiposity and Alzheimer's disease imaging markers across sex and race at midlife. | J Alzheimers Dis | 2026 | https://conductscience.org/library/papers/42249678 | PubMed |
| 42,183,943 | Agmatine protects against MAFLD via decreasing RBM15/IGF2BP2-mediated m6A modification of SREBP1. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42183943 | PubMed |
| 42,120,765 | The Liver-brain Axis: A Three-stage Model Linking MASLD to Cognitive Impairment and Dementia. | J Mol Neurosci | 2026 | https://conductscience.org/library/papers/42120765 | PubMed |
| 42,020,485 | Impact of liver cirrhosis etiology on results of diagnostic tests for minimal hepatic encephalopathy. | Sci Rep | 2026 | https://conductscience.org/library/papers/42020485 | PubMed |
1 to 10 of 27
See all 27 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38415019
GET https://conductscience.org/api/papers/v1/38415019/references?page=2